Mesoblast Ltd (MSB) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.084x

Based on the latest financial reports, Mesoblast Ltd (MSB) has a cash flow conversion efficiency ratio of -0.084x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-49.95 Million ≈ $-35.35 Million USD) by net assets (AU$597.44 Million ≈ $422.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Mesoblast Ltd - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Mesoblast Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Mesoblast Ltd total liabilities for a breakdown of total debt and financial obligations.

Mesoblast Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mesoblast Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Engie Energia Chile SA SN:ECL	0.025x
Shanghai Bright Power Semiconductor SHG:688368	0.045x
Establishment Labs Holdings Inc NASDAQ:ESTA	-0.688x
Sinosoft Co Ltd SHG:603927	-0.043x
Xiamen Solex High-Tech Industries Co Ltd SHG:603992	0.021x
Entra ASA OL:ENTRA	0.054x
Scatec Solar OL OL:SCATC	0.244x
Hangzhou Steam Turbine SHE:200771	0.014x

Annual Cash Flow Conversion Efficiency for Mesoblast Ltd (2005–2025)

The table below shows the annual cash flow conversion efficiency of Mesoblast Ltd from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Mesoblast Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$597.44 Million ≈ $422.73 Million	AU$-49.95 Million ≈ $-35.35 Million	-0.084x	+17.12%
2024-06-30	AU$480.36 Million ≈ $339.88 Million	AU$-48.46 Million ≈ $-34.29 Million	-0.101x	+19.98%
2023-06-30	AU$501.84 Million ≈ $355.08 Million	AU$-63.27 Million ≈ $-44.77 Million	-0.126x	+4.74%
2022-06-30	AU$497.04 Million ≈ $351.69 Million	AU$-65.78 Million ≈ $-46.54 Million	-0.132x	+27.87%
2021-06-30	AU$581.40 Million ≈ $411.38 Million	AU$-106.68 Million ≈ $-75.48 Million	-0.183x	-78.83%
2020-06-30	AU$549.33 Million ≈ $388.68 Million	AU$-56.37 Million ≈ $-39.88 Million	-0.103x	+14.59%
2019-06-30	AU$481.05 Million ≈ $340.37 Million	AU$-57.79 Million ≈ $-40.89 Million	-0.120x	+12.56%
2018-06-30	AU$546.01 Million ≈ $386.34 Million	AU$-75.01 Million ≈ $-53.08 Million	-0.137x	+25.64%
2017-06-30	AU$516.77 Million ≈ $365.64 Million	AU$-95.47 Million ≈ $-67.55 Million	-0.185x	-10.89%
2016-06-30	AU$528.16 Million ≈ $373.71 Million	AU$-88.00 Million ≈ $-62.26 Million	-0.167x	+16.58%
2015-06-30	AU$609.36 Million ≈ $431.16 Million	AU$-121.71 Million ≈ $-86.12 Million	-0.200x	-39.49%
2014-06-30	AU$571.72 Million ≈ $404.53 Million	AU$-81.86 Million ≈ $-57.92 Million	-0.143x	-66.87%
2013-06-30	AU$630.27 Million ≈ $445.95 Million	AU$-54.08 Million ≈ $-38.27 Million	-0.086x	+43.03%
2012-06-30	AU$478.85 Million ≈ $338.82 Million	AU$-72.12 Million ≈ $-51.03 Million	-0.151x	-171.78%
2011-06-30	AU$515.84 Million ≈ $364.99 Million	AU$108.23 Million ≈ $76.58 Million	0.210x	+182.38%
2010-06-30	AU$37.92 Million ≈ $26.83 Million	AU$-9.66 Million ≈ $-6.83 Million	-0.255x	+28.89%
2009-06-30	AU$25.79 Million ≈ $18.25 Million	AU$-9.24 Million ≈ $-6.54 Million	-0.358x	-51.39%
2008-06-30	AU$26.22 Million ≈ $18.55 Million	AU$-6.20 Million ≈ $-4.39 Million	-0.237x	+46.61%
2007-06-30	AU$20.54 Million ≈ $14.53 Million	AU$-9.10 Million ≈ $-6.44 Million	-0.443x	-66.55%
2006-06-30	AU$11.97 Million ≈ $8.47 Million	AU$-3.18 Million ≈ $-2.25 Million	-0.266x	-747.50%
2005-06-30	AU$19.26 Million ≈ $13.63 Million	AU$-604.81K ≈ $-427.94K	-0.031x	--

About Mesoblast Ltd

AU:MSB Australia Biotechnology

Market Cap

$2.00 Billion

AU$2.82 Billion AUD

Market Cap Rank

#6270 Global

#144 in Australia

Share Price

AU$2.20

Change (1 day)

+0.00%

52-Week Range

AU$1.57 - AU$3.07

All Time High

AU$5.21